Jun Shoji

2.2k total citations
91 papers, 1.6k citations indexed

About

Jun Shoji is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Allergy and Ophthalmology. According to data from OpenAlex, Jun Shoji has authored 91 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Public Health, Environmental and Occupational Health, 27 papers in Immunology and Allergy and 25 papers in Ophthalmology. Recurrent topics in Jun Shoji's work include Ocular Surface and Contact Lens (55 papers), Allergic Rhinitis and Sensitization (27 papers) and Dermatology and Skin Diseases (18 papers). Jun Shoji is often cited by papers focused on Ocular Surface and Contact Lens (55 papers), Allergic Rhinitis and Sensitization (27 papers) and Dermatology and Skin Diseases (18 papers). Jun Shoji collaborates with scholars based in Japan, United States and Italy. Jun Shoji's co-authors include Noriko Inada, Mitsuru Sawa, Nobuyuki Ebihara, Atsuki Fukushima, Shigeki Okamoto, Hiroshi Fujishima, Etsuko Takamura, Kenichi Namba, Yuichi Ohashi and Eiichi Uchio and has published in prestigious journals such as PLoS ONE, Scientific Reports and Ophthalmology.

In The Last Decade

Jun Shoji

85 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Shoji Japan 24 1.0k 515 508 445 351 91 1.6k
Mitchell H. Friedlaender United States 24 847 0.8× 463 0.9× 619 1.2× 241 0.5× 277 0.8× 93 1.8k
Kazuko Kitagawa Japan 13 466 0.5× 80 0.2× 351 0.7× 321 0.7× 86 0.2× 27 940
Katarzyna Rückemann-Dziurdzińska Poland 13 85 0.1× 75 0.1× 10 0.0× 34 0.1× 219 0.6× 31 1.2k
Michael Jarratt United States 26 22 0.0× 162 0.3× 46 0.1× 17 0.0× 1.3k 3.8× 62 1.9k
H.-W. Vohr Germany 16 157 0.2× 163 0.3× 3 0.0× 51 0.1× 350 1.0× 26 911
Franco Quagliata United States 14 133 0.1× 32 0.1× 6 0.0× 122 0.3× 71 0.2× 35 1.1k
B N Hudspith United Kingdom 21 54 0.1× 240 0.5× 5 0.0× 67 0.2× 53 0.2× 48 1.3k
Narsing A. Rao United States 17 84 0.1× 4 0.0× 1.4k 2.8× 123 0.3× 14 0.0× 36 1.8k
Alvin Volkman United States 16 36 0.0× 60 0.1× 8 0.0× 107 0.2× 37 0.1× 42 1.4k
Tobias Rogosch Germany 11 79 0.1× 63 0.1× 5 0.0× 118 0.3× 15 0.0× 26 957

Countries citing papers authored by Jun Shoji

Since Specialization
Citations

This map shows the geographic impact of Jun Shoji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Shoji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Shoji more than expected).

Fields of papers citing papers by Jun Shoji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Shoji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Shoji. The network helps show where Jun Shoji may publish in the future.

Co-authorship network of co-authors of Jun Shoji

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Shoji. A scholar is included among the top collaborators of Jun Shoji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Shoji. Jun Shoji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shoji, Jun, Ashley Vo, Edmund Huang, et al.. (2025). Daratumumab for Treatment of Recurrent FSGS and PGNMID in Kidney Transplant. American Journal of Transplantation. 25(8). S881–S881.
2.
Shoji, Jun & Nobuyuki Ebihara. (2025). Clinical characteristics and management of dupilumab-associated ocular surface disease in Japan. Japanese Journal of Ophthalmology. 70(1). 1–17.
3.
Hayashi, Takahiko, Toshiki Shimizu, Yusuke Hara, et al.. (2025). Mouse Model of Sutured Endothelial Keratoplasty Technique. Journal of Clinical Medicine. 14(13). 4442–4442.
4.
Vo, Ashley, Edmund Huang, Xiaohai Zhang, et al.. (2025). Daratumumab (Anti-CD38) Desensitization in HLA Sensitized Patients: Long-Term Follow-Up. American Journal of Transplantation. 25(8). S267–S267.
5.
Shoji, Jun, et al.. (2022). Two cases of dupilumab-associated conjunctivitis with high expression of IL-8 mRNA on the ocular surface: a case report. Allergy Asthma and Clinical Immunology. 18(1). 89–89. 2 indexed citations
6.
7.
8.
Miyazaki, Dai, Kazumi Fukagawa, Shigeki Okamoto, et al.. (2020). Epidemiological aspects of allergic conjunctivitis. Allergology International. 69(4). 487–495. 92 indexed citations
9.
Inada, Noriko, et al.. (2017). Histamine H1 and H4 receptor expression on the ocular surface of patients with chronic allergic conjunctival diseases. Allergology International. 66(4). 586–593. 14 indexed citations
10.
Miyazaki, Dai, Atsuki Fukushima, Yuichi Ohashi, et al.. (2016). Steroid-Sparing Effect of 0.1% Tacrolimus Eye Drop for Treatment of Shield Ulcer and Corneal Epitheliopathy in Refractory Allergic Ocular Diseases. Ophthalmology. 124(3). 287–294. 38 indexed citations
11.
Miyazaki, Dai, Atsuki Fukushima, Yuichi Ohashi, et al.. (2016). Steroid sparing effect of 0.1% tacrolimus eye drops for treatment of shield ulcer and corneal epitheliopathy in refractory allergic ocular diseases. Investigative Ophthalmology & Visual Science. 57(12). 303–303.
12.
Shoji, Jun, Tohru Sakimoto, Noriko Inada, et al.. (2016). A diagnostic method for herpes simplex keratitis by simultaneous measurement of viral DNA and virus-specific secretory IgA in tears: an evaluation. Japanese Journal of Ophthalmology. 60(4). 294–301. 24 indexed citations
13.
Nakashizuka, Hiroyuki, Jun Shoji, Hiroyuki Shimada, & Mitsuko Yuzawa. (2016). EXPERIMENTAL VISUALIZATION AND QUANTIFICATION OF VITREOUS CONTAMINATION FOLLOWING INTRAVITREAL INJECTIONS. Retina. 36(10). 1882–1887. 10 indexed citations
14.
Ebihara, Nobuyuki, Yuichi Ohashi, Eiichi Uchio, et al.. (2009). A Large Prospective Observational Study of Novel Cyclosporine 0.1% Aqueous Ophthalmic Solution in the Treatment of Severe Allergic Conjunctivitis. Journal of Ocular Pharmacology and Therapeutics. 25(4). 365–372. 84 indexed citations
15.
Shoji, Jun, et al.. (2007). Concentration of Soluble Interleukin-6 Receptors in Tears of Allergic Conjunctival Disease Patients. Japanese Journal of Ophthalmology. 51(5). 332–337. 26 indexed citations
16.
Takano, Y., Murat Doğru, Masaru Tanaka, et al.. (2006). Preliminary Results of the World Ocular Allergy Study: Comparison of the Characteristics of Patients With Severe Ocular Allergies in Italy and Japan. Investigative Ophthalmology & Visual Science. 47(13). 4991–4991. 1 indexed citations
17.
Shoji, Jun, et al.. (2004). [Histopathological study of lattice corneal dystrophy with L 527 R mutation of transforming growth factor-beta induced gene].. PubMed. 108(2). 118–23. 5 indexed citations
18.
Shoji, Jun. (2003). Efficacy of Tear Eosinophil Cationic Protein Level Measurement Using Filter Paper for Diagnosing Allergic Conjunctival Disorders. Japanese Journal of Ophthalmology. 47(1). 64–68. 27 indexed citations
19.
Mita, Akira, et al.. (1979). Enhancement and suppression in production of IgM-antibody in mice treated with purified saponins.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 31(8). 223–7. 17 indexed citations
20.
Shoji, Jun. (1961). Preliminary studies on the isolation of carzinostatin complex and its characteristics. Studies on the streptomyces antibiotics. Xxxxiii.. The Mouseion at the JAXlibrary (Jackson Laboratory). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitchell H. Friedlaender Breakdown of academic impact, for papers by Kazuko Kitagawa Breakdown of academic impact, for papers by Katarzyna Rückemann-Dziurdzińska Breakdown of academic impact, for papers by Michael Jarratt Breakdown of academic impact, for papers by H.-W. Vohr Breakdown of academic impact, for papers by Franco Quagliata Breakdown of academic impact, for papers by B N Hudspith Breakdown of academic impact, for papers by Narsing A. Rao Breakdown of academic impact, for papers by Alvin Volkman Breakdown of academic impact, for papers by Tobias Rogosch
Rankless by CCL
2026